Two-part phase I trial to investigate the tolerability and pharmacokinetics of single doses and multiple doses of delafloxacin in volunteers.
Phase of Trial: Phase I
Latest Information Update: 29 Jul 2008
At a glance
- Drugs Delafloxacin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors Melinta Therapeutics
- 29 Jul 2008 New trial record.